Back
ESC Professional Premium Access

Rate control first for most atrial fibrillation patients: beta-blocker and/or digitalis?

Session: The management challenge of atrial fibrillation in HFrEF and HFpEF
Topic: Pathophysiology and Mechanisms
Speaker: Professor D. Kotecha (Birmingham, GB)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
34 presentations
0 follower

4 more presentations in this session

Atrial fibrillation and heart failure: epidemiology, risk factors and prevention.

Speaker: Professor L. Kober (Copenhagen, DK)

Access
Slides
Video
Thumbnail

How good is pulmonary vein isolation in atrial fibrillation with heart failure?

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Access
Slides
Video
Thumbnail

Atrioventricular node ablation and CRT is the future.

Speaker: Professor G. Hindricks (Berlin, DE)

Access
Slides
Video
Thumbnail

The management challenge of atrial fibrillation in HFrEF and HFpEF – discussion.

Speaker: Doctor E. O'Meara (Montreal, CA)

Access
Slides
Video
Thumbnail

Access the full session

The management challenge of atrial fibrillation in HFrEF and HFpEF

Speakers: Professor D. Kotecha, Professor L. Kober, Associate Professor T. Potpara, Professor G. Hindricks, Doctor E. O'Meara
Access
Video
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb